GENE ONLINE|News &
Opinion
Blog

China NMPA
AstraZeneca’s Treatment for Chronic Kidney Disease Wins Yet Another Approval
2022-09-05
Lepu, HanX Scores China Approval For PD-1 Inhibitor
2022-07-27
BeiGene Granted NMPA Approval to Treat World’s Most Prevalent Esophageal Cancer
2022-04-20
Innovent’s PCSK-9 Antibody Meets Primary Endpoints in Two Phase 3 Studies
2022-02-18
China Gives Conditional Approval to Pfizer’s Covid-19 Oral Antiviral
2022-02-14
GSK’s Benlysta Bags Approval for Lupus Nephritis Treatment in China
2022-02-14
China’s CANbridge Reports Positive Phase 1 Data of Contender to AstraZeneca’s Complement Inhibitor
2022-02-08
Antengene’s XPO1 Inhibitor Receives First-In-Class Approval in China for Multiple Myeloma
2021-12-20
Brii Bio’s COVID-19 Antibody Cocktail Gets the Greenlight in China
2021-12-09
JW Therapeutics’ CAR-T Approval in China Comes On the Heels of its Rival
2021-09-08
Chinese Regulator Accepts BeiGene’s Tislelizumab sBLA for Nasopharyngeal Cancer
2021-08-23
Gilead’s Yescarta Becomes First CAR-T Therapy to Score Regulatory Approval in China
2021-06-27
Innovent, Lilly Bag Third Approval for PD-1 Inhibitor Tyvyt in China
2021-06-07
Forxiga Gains Approval in China for Multiple Cardio-Related Diseases
2021-02-07
BeiGene’s Immunotherapy Drug Shines in Phase ESCC Trial
2021-01-31
1 2 3
LATEST
Company Presentations at BIO 2024 Inspire Partnering
2024-06-14
GV Regains Compliance with Nasdaq Minimum Bid Price Requirement
2024-06-13
ARPA-H Fast-Tracks Biotech Startups: Funding Insights from BIO 2024 Panel
2024-06-12
Gene Therapy Innovations and Financial Challenges for the Future of Medicine
2024-06-12
BIO Releases DEI Survey in Partnership with Korn Ferry
2024-06-11
Advancing Healthcare Accessibility and Sustainable Development
2024-06-11
New CRISPR Method Enables Gene Edits in Cockroaches and All Insects
2024-06-11
EVENT
Scroll to Top